Sorafenib in the treatment of AML patients with FLT3-ITD mutation: a cohort study
Latest Information Update: 15 Nov 2016
At a glance
- Drugs Sorafenib (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 25 Jul 2014 New trial record
Latest Information Update: 15 Nov 2016